Eric Elenko

Co-founder & President @Puretech Health

Boston, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Sep 2005 — Present

Co-founder & President @Puretech Health

View department →

Boston, MA, US

PureTech pioneered the “hub and spoke” model of developing therapeutics and starting companies. PureTech\'s R&D engine has resulted in the development of 29 therapeutics and therapeutic candidates, including three that have been approved by the U.S. Food and Drug Administration. My work includes:Co-founding and scaling multiple PureTech subsidiary companies from a blank sheet of paper (e.g, Karuna Therapeutics) that have collectively created billions of dollars in value.Serving on the boards of six companies, including remuneration, science & technology and audit committees.Leading programs from discovery through mid-stage clinical development including building teams, filing INDs, interacting with the FDA (e.g, pre-IND through end of Phase 2 meetings) and conducting multiple global Phase 1and Phase 2 studies.Playing a key role in fundraising for PureTech and its subsidiary companies.

EDUCATION

1991 — 1995

Swarthmore College

BA, Biology

1995 — 2001

University of California, San Diego

PhD, Biomedical Sciences

ABOUT ERIC ELENKO

As Co-Founder and President of PureTech Health (LSE: PRTC), I helped pioneer the hub-and-spoke model of biotech venture creation. I serve as an entrepreneur starting companies, an operator building and leading the companies, an investor who is part of venture capital syndicates and a Board member. The companies I have co-founded have generated billions of dollars in value and have resulted in multiple FDA-approved therapeutics. My work spans the full life cycle of innovation: identifying scientific breakthroughs, creating drugs, building teams from the ground up, leading programs through global clinical trials, securing financing and serving as a board member from Series A through IPO. Specialties: Venture capital, life science entrepreneurship and innovation, sourcing & due diligence, drug development, C-level management, Board membership.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.